Gadi Riesenfeld
Director at NurExone Biologic.
Earliest Form D on file: Apr 2025
2 filings at 1 company
NurExone Biologic
Biotech
Director
- Signed
- Named
- Size is amount sold, up to $30M
Filings
2- Aug 27, 2025
Equity, option to acquire, security to be acquired, other, named · Form D
$148K
of $243K
Aug 27, 2025Equity, option to acquire, security to be acquired, other
Named, Director
$148K
$243K
- Apr 22, 2025
Equity, option to acquire, security to be acquired, other, named · Form D
$1.6M
of $3.8M
Apr 22, 2025Equity, option to acquire, security to be acquired, other
Named, Director
$1.6M
$3.8M
Network
At NurExone Biologic
6 people- Together on 2 filings
Executive Officer, signed as Chief Financial Officer
- Together on 2 filings
Executive Officer, Director
- Together on 2 filings
Executive Officer, Director
- Together on 2 filings
Director
- Together on 2 filings
Director
Director